These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15747987)

  • 1. [Therapy with oral antidiabetic drugs].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy with insulin].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):164-5. PubMed ID: 15747988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
    Winkler G; Baranyi E
    Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral antidiabetic agents for the general practitioner].
    Siegmund T
    MMW Fortschr Med; 2009 Apr; 151(14):86, 88-91; quiz 92. PubMed ID: 19504847
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inadequate blood glucose control with oral antidiabetic drugs. Early conversion to insulin].
    MMW Fortschr Med; 2002 Jul; 144(27-28):61. PubMed ID: 12198890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in metabolic control after interruption of oral hypoglycemic agents in type II diabetic patients with secondary failure during combined therapy].
    De Mattia G; Laurenti O; Tullo MG; Ventura C; Albi F
    Clin Ter; 1988 Oct; 127(2):119-22. PubMed ID: 2976347
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin therapy of diabetes].
    Lechleitner M; Roden M; Weitgasser R; Ludvik B; Fasching P; Hoppichler F; Kautzky-Willer A; Schernthaner G; Prager R; Wascher TC
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S54-61. PubMed ID: 27052221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral antidiabetic drugs].
    Tauber JP
    Rev Prat; 1999 Jan; 49(1):46-50. PubMed ID: 9926716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
    Pernet A; Bäbler M; Ganz K
    Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
    [No Abstract]   [Full Text] [Related]  

  • 12. 2008 resource guide. Type 2 drugs. There are now six classes of diabetes pills and several combination oral meds. Each has a different way of helping you control your diabetes.
    McCarren M
    Diabetes Forecast; 2008 Jan; 61(1):RG7-9. PubMed ID: 18290287
    [No Abstract]   [Full Text] [Related]  

  • 13. [The peroral therapy of non-insulin-dependent diabetes mellitus].
    Ametov AS; Granovskaia-Tsvetkova AM
    Ter Arkh; 1994; 66(10):17-9. PubMed ID: 7863436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral antidiabetic drugs--1. For each patient the proper drug].
    Bachmann W
    MMW Fortschr Med; 2000 Mar; 142(9):41-4. PubMed ID: 10795481
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L; Hirsch IB
    Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making the transition from oral to insulin therapy.
    Riddle MC
    Am J Med; 2005 May; 118 Suppl 5A():14S-20S. PubMed ID: 15850549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of incretin clinical trials.
    Garber AJ; Spann SJ
    J Fam Pract; 2008 Sep; 57(9 Suppl):S10-8. PubMed ID: 18786339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feature selection and classification model construction on type 2 diabetic patients' data.
    Huang Y; McCullagh P; Black N; Harper R
    Artif Intell Med; 2007 Nov; 41(3):251-62. PubMed ID: 17707617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.